Related Experiment Video
Updated: Apr 9, 2026
Adapting Human Videofluoroscopic Swallow Study Methods to Detect and Characterize Dysphagia in Murine Disease Models
Published on: March 1, 2015
Clinical characteristics and factors associated with dysphagia in idiopathic inflammatory myopathy: A cross-sectional
Biwei Pei1, Yan Teng1, Dandan Dong1
1Department of Rheumatology and Immunology, Ma'anshan People's Hospital, Ma'anshan 243000, People's Republic of China.
Objective:
To investigate the clinical and laboratory characteristics of idiopathic inflammatory myopathy (IIM) patients with dysphagia and determine associated factors.
Methods:
We conducted an observational study of 96 patients with IIM in the Department of Rheumatology and Immunology at Ma'anshan People's Hospital from September 2019 to June 2024, whose swallowing function was assessed and recorded. Clinical and laboratory characteristics were compared between patients with and without dysphagia in this cross-sectional study. Logistic regression analysis was used to identify factors associated with dysphagia in patients with IIM.
Results:
Among the 96 patients with IIM, 20 (21%) experienced dysphagia. The incidence was 2 of 9 patients (22%) with polymyositis, 12 of 54 patients (22%) with dermatomyositis, 2 of 27 patients (7%) with antisynthetase syndrome, and 4 of 6 patients (67%) with immune-mediated necrotizing myopathy (IMNM), with significant differences (P=0.015). Patients with dysphagia exhibited significantly higher levels of creatine kinase-MB isoenzyme (CK-MB), lactate dehydrogenase, serum ferritin, rates of concomitant tumor, and positivity for autoantibodies directed against transcription intermediary factor 1-γ (anti-TIF1γ) and against the signal recognition particle (anti-SRP) than those without (all P<0.05). Logistic regression analysis indicated that anti-SRP antibodies, anti-TIF1γ antibodies, concomitant tumor, and elevated CK-MB levels were independent risk factors for the development of dysphagia in patients with IIM. Receiver operator characteristic curve (ROC) analysis demonstrated that the areas under the curve (AUC) for anti-TIF1γ antibody, concomitant tumor, and CK-MB levels alone in predicting dysphagia in IIM patients were 0.699, 0.759, and 0.656, respectively. The combined predictive model yielded an area under the curve (AUC) of 0.914.
Conclusion:
Dysphagia is not rare in patients with IIM. It is important to be vigilant for the occurrence of dysphagia in IIM patients positive for anti-SRP antibodies, anti-TIFγ antibodies, concomitant tumors, and elevated CK-MB levels. Anti-TIF1γ antibodies, concomitant tumors, and elevated CK-MB levels may have potential value in identifying IIM patients at higher risk of dysphagia.
Related Concept Videos
01:15Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Myocarditis II: Clinical Features and Diagnostic Tests
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...